Clene Inc.

NASDAQ:CLNN

Biotechnology

Healthcare
$3.50 +1.35%

+$0.08 today

Market cap
$50.40M
Beta
0.92
P/E (TTM)
-2.1
EPS (TTM)
-$2.88
52W Low $3.25High $13.50

Volume 0.12M

Average 0.50M

Income Statement

Follow revenue through to earnings.

Revenue

$200,000.00

FY 2025 · Annual

-41.5% YoY

Operating Income

-$23.08M

FY 2025 · Annual

Net Income

-$26.17M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue723K473K654K342K200K
Cost of Revenue289K26K121K70K43K
Gross Profit434K447K533K272K157K
Gross Margin60.0%94.5%81.5%79.5%78.5%
Research & Development28.42M31.92M26.66M20.06M14.01M
Selling, General & Admin18.81M16.16M14.42M13.31M9.23M
Operating Expenses50.41M48.86M41.07M33.37M23.24M
Depreciation & Amortization955K1.02M1.71M1.65M1.5M
EBITDA(8.34M)(25.6M)(43.24M)(33.69M)(22M)
EBITDA Margin-1153.9%-5412.9%-6611.8%-9851.2%-10998.0%
Operating Income(49.98M)(48.41M)(40.54M)(33.09M)(23.08M)
Operating Margin-6912.6%-10234.5%-6198.8%-9676.3%-11541.5%
Interest Income001.39M865K223K
Interest Expense870K3.3M4.56M4.06M2.68M
Other Income / Expenses39.81M18.49M(8.96M)(6.31M)(3.09M)
Income Before Tax(10.17M)(29.92M)(49.5M)(39.4M)(26.17M)
Pre-Tax Margin-1406.4%-6325.2%-7569.4%-11520.5%-13086.5%
Income Tax Expense(428K)0000
Net Income(9.74M)(29.92M)(49.5M)(39.4M)(26.17M)
Net Margin-1347.2%-6325.2%-7569.4%-11520.5%-13086.5%
EPS (Basic)(3.16)(4.69)(9.43)(5.67)(2.65)
EPS (Diluted)(3.16)(4.69)(9.43)(5.67)(2.65)
Weighted Avg Shares3.08M3.26M5.25M6.95M9.86M
Weighted Avg Shares (Diluted)3.08M3.26M5.25M6.95M9.86M

CLNN Earnings Waterfall · TTM

NASDAQ:CLNN · Revenue to Net Income

Key Ratios

EPS$-3.25
Gross Margin-499.1%
Net Margin-37978.2%
P/E Ratio-1.6
P/S Ratio2523.1

Analysis

$134.0K of revenue converted into -$33.5M of net income for the selected period. Gross margin is -499.1% and net margin is -37978.2%, showing how much revenue survives after costs and taxes. EPS is $-3.25, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 21, 2026

How much revenue does CLNN generate?

Clene Inc. (CLNN) reported $200,000.00 of revenue in fiscal 2025.

Is CLNN profitable?

Clene Inc. (CLNN) reported -$26.17M of net income, with a net margin of -13086.5%.